Niemann Pick Type C Disease – Competitive Analysis: New Innovations Trends, Research, Global Share and Growth Factor and Forecast: 2022-2031

Niemann Pick Type-C Disease Competitive Overview

Niemann Pick Type-C Disease (NPC) is a progressive autosomal recessive genetic disorder of lysosome storage due to an inability of the body to transport cholesterol and other fatty substances (lipids) inside of cells. The accumulation of these substances damages the affected areas. It can range from a fatal disorder within the first few months after birth (neonatal period) to a late onset, chronic progressive disorder that remains undiagnosed well into adulthood. It affects both males and females equally. NPC is estimated to occur in 1 in 100,000-120,000 live births.

Enquire before purchasing this report: https://www.sdki.jp/sample-request-111420

The onset of symptoms may begin at any age, most commonly in school age children; however, infants, adolescents and adults can all be affected by the disease. With the progression of disease, children may experience developmental delays, challenges with motor skills (e.g. increased clumsiness and abnormal posturing) and difficulty in making vertical eye movements. Dystonia and seizures are common in the patients suffering from NPC.

Several tests are available for the diagnosis of NPC. These tests include biochemical testing, molecular genetic testing, NPC screening using biomarkers among others. No marketed drugs are currently available for NPC in the U.S and only one marketed drug i.e. Miglustat is available in European Union (EU) and Japan. The drug development companies are involved in quest to develop an effective drug and better treatment strategies. There are several companies utilizing their proprietary technologies for the development of effective and better drugs.
The therapeutic pipeline of NPC Disease consists of approximately 9+ products in different stages of development along with single marketed drug. Currently 2+ drugs are in Phase III development and major drugs are in pre-clinical and discovery stage.

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-111420

Top Company Analysed

Some of the key players include Orphazyme, CTD Holdings, Mallinckrodt Pharmaceuticals, IntraBio, Perlara, Neurotrope BioScience, Evox Therapeutics, Okklo Life Sciences, Amicus Therapeutics and Johnson & Johnson.
Scope of the report:
• The report provides the marketed drugs information including its approval details, development activities and details of patent expiry
• Provides an overview of therapeutic pipeline activity for Niemann Pick Type-C Disease across the complete product development cycle including all clinical and non-clinical stages
• The report comprises of detailed description of Niemann Pick Type-C Disease therapeutic products with key coverage of developmental activities including licensing & collaboration deals, patents issued, designations, technologies and chemical information
• Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration
Reasons to buy:
• The Niemann Pick Type-C Disease competitive report presents the detailed profile of drugs. The analysis offered in the report is a combination of deep dive secondary research and input from Key Opinion Leader of the industry
• The report presents a quick review of the current scenario regarding the drug development of the indication at one glance
• The report covers in-depth analysis of prominent industry peers with a primary focus on company consolidation, designation, technology, agreements and patents regarding the therapy
• Detailed examination on diagnosis, treatment and guidelines prevailing in the industry
• Examination of industry attractiveness with the help of approval timelines
• The study comprehensively covers the market across drugs in different phases of development

Customization Options:

The Niemann Pick Type-C Disease competitive analysis report can be customized to the country level or any other competitive segment. Besides this, UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients.

Airport Passenger Boarding Bridges Market
Parachute Market
Saudi Arabia Defense Market
Naval Combat Systems Market
Medium Caliber Ammunition Market
Europe Commercial Aircraft Cabin Interior Market
Civil Aerospace Simulation and Training Market
Middle-East and Africa Small UAV Market
More Electric Aircraft Market
Smart Airport Market
Commercial Airport Lighting Market
Gunshot Detection Systems Market
Aircraft Synthetic Vision Systems Market
Latin America Inflight Catering Market
Business Jet Market
Airline Route Profitability Software Market

Related posts

Leave a Comment